fosinopril has been researched along with propranolol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervenka, J; Dineen, M; O'Connor, DT; Sullivan, PA | 1 |
| Agaev, MM; Azizov, VA | 1 |
| Chen, H; Gu, Q; Li, C; Xu, X; Zheng, Z | 1 |
| Agaev, MM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fosinopril and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for fosinopril and propranolol
| Article | Year |
|---|---|
Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Exercise; Fosinopril; Hormones; Humans; Hypertension; Male; Middle Aged; Potassium; Proline; Propranolol; Random Allocation; Renin; Rest | 1989 |
[Clinical efficiency of the use of monopril, propanolol and heparinum in stationary rehabilitation of patients with myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Fibrinolytic Agents; Fosinopril; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 2008 |
4 other study(ies) available for fosinopril and propranolol
| Article | Year |
|---|---|
[Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diastole; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Electrocardiography; Fosinopril; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Propranolol; Systole; Vasodilator Agents; Ventricular Function, Left | 2003 |
Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; Blotting, Western; Capillaries; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Eye Proteins; Fosinopril; Immunohistochemistry; Male; Microscopy, Electron; Propranolol; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |